CME Group (NASDAQ:CME) Price Target Cut to $208.00

CME Group (NASDAQ:CME) had its target price cut by equities research analysts at Barclays from $228.00 to $208.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “equal weight” rating on the financial services provider’s stock. Barclays‘s target price would indicate a potential upside of 6.23% from the company’s previous close.

CME has been the subject of several other research reports. Keefe, Bruyette & Woods reiterated a “market perform” rating and set a $226.00 price objective on shares of CME Group in a report on Wednesday, July 3rd. Rosenblatt Securities restated a “sell” rating and issued a $187.00 target price (up previously from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Morgan Stanley raised their target price on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 9th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $210.00 target price (down previously from $235.00) on shares of CME Group in a research note on Friday, April 5th. Finally, Bank of America raised their target price on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a research note on Thursday, April 25th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, CME Group currently has an average rating of “Hold” and an average target price of $215.82.

CME Group Stock Up 1.1 %

Shares of NASDAQ CME opened at $195.80 on Wednesday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $70.50 billion, a PE ratio of 22.28, a price-to-earnings-growth ratio of 5.15 and a beta of 0.52. The stock’s fifty day simple moving average is $202.44 and its two-hundred day simple moving average is $207.63. CME Group has a 12-month low of $180.11 and a 12-month high of $223.80.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.44 by $0.06. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the firm earned $2.42 EPS. As a group, analysts expect that CME Group will post 9.74 EPS for the current fiscal year.

Insiders Place Their Bets

In other CME Group news, Director Elizabeth A. Cook sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $211.52, for a total value of $211,520.00. Following the transaction, the director now directly owns 18,241 shares of the company’s stock, valued at approximately $3,858,336.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider Hilda Harris Piell sold 7,140 shares of CME Group stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the sale, the insider now owns 29,256 shares of the company’s stock, valued at approximately $6,153,999.60. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Elizabeth A. Cook sold 1,000 shares of CME Group stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $211.52, for a total transaction of $211,520.00. Following the sale, the director now directly owns 18,241 shares in the company, valued at approximately $3,858,336.32. The disclosure for this sale can be found here. Insiders have sold 54,290 shares of company stock valued at $11,393,700 in the last ninety days. 0.30% of the stock is currently owned by corporate insiders.

Institutional Trading of CME Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CME. Norges Bank acquired a new position in shares of CME Group in the fourth quarter worth $959,260,000. Capital International Investors grew its stake in shares of CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after acquiring an additional 3,069,806 shares in the last quarter. Capital Wealth Planning LLC acquired a new position in shares of CME Group in the fourth quarter worth $253,563,000. Capital World Investors grew its stake in shares of CME Group by 8.7% in the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after acquiring an additional 1,172,575 shares in the last quarter. Finally, M&G Plc acquired a new position in shares of CME Group in the first quarter worth $156,631,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.